Palvella Therapeutics, Inc. (PVLA) Other Non Operating Income (2016 - 2022)
Palvella Therapeutics (PVLA) has disclosed Other Non Operating Income for 11 consecutive years, with $464000.0 as the latest value for Q4 2024.
- On a quarterly basis, Other Non Operating Income rose 261.11% to $464000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $453000.0, a N/A change, with the full-year FY2024 number at $1.1 million, changed N/A from a year prior.
- Other Non Operating Income was $464000.0 for Q4 2024 at Palvella Therapeutics, up from -$75000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $884000.0 in Q1 2021 to a low of -$1.8 million in Q4 2020.
- A 5-year average of $25200.0 and a median of $32500.0 in 2023 define the central range for Other Non Operating Income.
- Peak YoY movement for Other Non Operating Income: plummeted 2334.55% in 2020, then skyrocketed 1573.33% in 2021.
- Palvella Therapeutics' Other Non Operating Income stood at -$1.8 million in 2020, then surged by 120.62% to $378000.0 in 2021, then tumbled by 185.98% to -$325000.0 in 2022, then rose by 11.38% to -$288000.0 in 2023, then surged by 261.11% to $464000.0 in 2024.
- Per Business Quant, the three most recent readings for PVLA's Other Non Operating Income are $464000.0 (Q4 2024), -$75000.0 (Q3 2024), and $122000.0 (Q2 2024).